Posts for Category: Press Releases

ACMT is pleased to announce the 2024 ACMT Annual Scientific Meeting (ASM) and Symposia taking place April 10 - 14 at the Omni Shoreham Hotel in Washington, DC.

Under a U.S. Food and Drug Administration (FDA) contract with the American College of Medical Toxicology (ACMT), the Toxicology Investigators Consortium (ToxIC) is expanding its Drug Overdose Toxico-Surveillance (DOTS) Reporting Program evaluating patients with opioid and stimulant overdoses.

“The 2023 Virtual Seminar in Forensic Toxicology: Expanding Worlds of Cannabinoids & Polydrug Exposures” is a two-day virtual seminar featuring distinguished industry experts addressing some of the most crucial topics affecting the medical and public health landscape today. Topics covered include cannabis and alternative cannabinoid impairment, and new research on medical legal death investigations involving polydrug exposures such as fentanyl, xylazine, benzodiazepines.

Under a U.S. Food and Drug Administration (FDA) contract awarded to the American College of Medical Toxicology’s (ACMT), the Toxicology Investigators Consortium (ToxIC) will examine the real-world administration of naloxone by community members, fire and police departments, and emergency medical services (EMS) personnel.

The CDC has collaborated with ACMT's ToxIC, a multicenter research network led by physicians specializing in medical toxicology, to develop a comprehensive toxico-surveillance dashboard capturing real-time data on nonfatal overdoses involving fentanyl.

American College of Medical Toxicology (ACMT) symposium will address the ethics, psychology, management, and global epidemiology of the suicidal patient through a toxicology lens. 

Important study findings recently published in the Journal of Medical Toxicology (JMT) dovetail with the new change in the Data 2000 (“X”) Waiver process for prescribing buprenorphine. Findings demonstrate that a brief education session led clinicians to an increase in the recognition of opioid withdrawal and initiation of buprenorphine treatment for patients in the emergency department.

This one-day symposium draws on the expertise of professionals from multiple medical and social science fields to address drug/medication-related issues and psychosocial issues faced by pregnant women who have substance use disorders. This event, which will take place on Thursday, March 10, kicks off 4 days of programming as part of the American College of Medical Toxicology (ACMT) 2022 Annual Scientific Meeting. 

The American College of Medical Toxicology (ACMT) 2022 Annual Scientific Meeting (ASM) will be held virtually from Friday, March 11 through Sunday, March 13th. This event will be preceded by ACMT’s 1-Day Virtual Symposium “Drug Science Meets Social Science: Substance Use, Pregnancy, and Baby” on Thursday, March 10.

The American College of Medical Toxicology (ACMT) Toxicology Investigators Consortium (ToxIC) Fentanyl Analog Study has detected an outbreak of illicit benzodiazepine co-exposures in patients seen in the emergency department.